opicapone 50 MG Oral Capsule

RxCUI: 2362180
RxNorm name: opicapone 50 MG Oral Capsule
Display name: opicapone 50 MG Oral Capsule
Full name: opicapone 50 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ONGENTYS	OPICAPONE	Amneal Pharmaceuticals LLC	a511a531-112e-43f8-a43f-5334b0efe979	2025-10-15	Warnings, Adverse reactions	Exact identifier rxcui: 2362180

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a511a531-112e-43f8-a43f-5334b0efe979	opicapone 50 MG Oral Capsule [PSN] · opicapone 50 MG Oral Capsule [SCD]	2	9	These highlights do not include all the information needed to use ONGENTYS ® safely and effectively. See full prescribing information for ONGENTYS ® . ONGENTYS ( opicapone ) capsules, for oral use Initial U.S. Approval: 20 20	20251015